Richard Bakemeier
About
In The Last Decade
Richard Bakemeier
34 papers receiving 472 citations
Peers
Comparison fields: 5 of 75
- Oncology 158
- Pathology and Forensic Medicine 130
- Pulmonary and Respiratory Medicine 125
- Hematology 98
- Physiology 90
Countries citing papers authored by Richard Bakemeier
This map shows the geographic impact of Richard Bakemeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bakemeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bakemeier more than expected).
Fields of papers citing papers by Richard Bakemeier
This network shows the impact of papers produced by Richard Bakemeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bakemeier. The network helps show where Richard Bakemeier may publish in the future.
Co-authorship network of co-authors of Richard Bakemeier
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Bakemeier. A scholar is included among the top collaborators of Richard Bakemeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Bakemeier. Richard Bakemeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Cancer education—lessons from the past | 1 |
| 2 | 14 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 27 | |
| 6 | 12 | |
| 7 | 9 | |
| 8 | Clinical oncology for medical students and physicians : a multidisciplinary approach | 12 |
| 9 | Treatment of advanced refractory lymphoma with teniposide and lomustine. | 3 |
| 10 | 7 | |
| 11 | 7 | |
| 12 | 64 | |
| 13 | 4 | |
| 14 | 7 | |
| 15 | 68 | |
| 16 | 16 | |
| 17 | 9 | |
| 18 | 5 | |
| 19 | 37 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.